Biological virus is a non-cellular life form characterized by its small size and simple structure, usually containing only one type of nucleic acid, either DNA or RNA.
Although viruses often evoke fear, advancements in scientific research have enabled the use of partial or complete viral components, or processed viruses, to stimulate the human immune system to produce specific antibodies and immune cells. This has given rise to the concept of viral vaccines.
The development of viral vaccines undergoes rigorous scientific investigation and clinical trials to ensure their safety and efficacy. Common viral vaccines include influenza vaccines, rabies vaccines, chickenpox vaccines, hepatitis vaccines, and pneumonia vaccines.
In the study of viruses, the purification process is an essential step. High-purity viral samples allow for more detailed research, and advanced separation and purification technologies play a critical role in the preparation of viral vaccines.
When it comes to vaccine purification methods, affinity chromatography, ion exchange chromatography, and hydrophobic chromatography may come to mind first. However, gel filtration chromatography is often overlooked. In this article, we will focus on the application of gel filtration chromatography resin in the purification of viral vaccines.
Gel Filtration Chromatography (GFC), also known as Size Exclusion Chromatography (SEC), separates samples based on molecular size by utilizing the pore size of spherical gel particles.
Diagram of Gel Filtration Chromatography
Chromstar® 4FF, a representative gel filtration chromatography resin, is commonly used in the purification of recombinant proteins, antibodies, nucleic acids, viruses, virus-like particles, and polysaccharides. It has shown outstanding performance in influenza vaccines: on one hand, it can remove ovalbumin from egg-based influenza vaccines; on the other hand, it achieves excellent results in both HA yield and protein removal rate in cell-based influenza vaccines.
Name | Chromstar® 4FF |
Chromatography Resin Type | Gel Filtration |
Matrix | Cross-linked Agarose, 4% |
Particle Size Range | 45~165 μm |
Separation Range | Spherical Molecules: 60 kDa~20,000 kDa Linear Molecules: 20 kDa~6,000 kDa |
Recommended Flow Rate | 90~200 cm/h* |
Maximum Flow Rate | 250 cm/h |
Maximum Back Pressure | 0.3 MPa |
Working Temperature | 4-30°C |
pH Stability** | 2-14 |
Compatible Solvents | Common aqueous solutions, 30% isopropanol, 75% ethanol, 1M NaOH, 1M acetic acid, 6M guanidine hydrochloride, 8M urea |
*When the bed height is ≥ 60 cm, it is recommended to reduce the flow rate to 45-60 cm/h.
**The physicochemical properties and functionality of the chromatography resin remain stable after being placed at 40°C and pH 2-14 for 7 days.
Purification of Influenza Virus Vaccine using Chromstar® 4FF
Resin: Chromstar® 4FF
Column: Chrom-LinX® 16/700 (H=60 cm)
Sample: Influenza virus
Sample Volume: 10 mL
Flow Rate: 6 mL/min
Buffer: 10 mM PBS
Purification Cycle | HA Recovery Rate | Protein Removal Rate |
First Cycle | 96% | 47% |
Second Cycle | 92% | 48% |
Third Cycle | 91% | 48% |
Summary: After three rounds of purification using Chromstar® 4FF, the HA recovery rate consistently exceeded 90%, and the protein removal rate reached 47%.
Bulk Packing Materials | ||
Product Name | Catalog No. | Specification |
Chromstar® 4FF | 1010-1121 | 25 mL |
1010-1122 | 100 mL | |
1010-1123 | 500 mL | |
1010-1124 | 1L | |
1010-1125 | 5L | |
1010-1126 | 10L | |
1010-1127 | 20 L |
Link With Us Now!